Zenome(ZNA)

active
Blockchain based genomic database

This listing is incomplete as a result of the ICO failing to respond to our numerous requests for more information.

"Zenome is a decentralized blockchain based database of genomic data. This platform enables users to manage their genomic data while ensuring  privacy and the ability to earn profit from selling access to various parts of the genome. It will help provide data for drug development and for the research in scientific and medical fields."


Use of Token

ZNA is Zenome's native token. ZNA is an Ethereum based token. There will be a total of 3.5 million ZNA tokens, 45% of which will be offered for sale via the ICO. Users who upload their genomic data to the system, will pay a reward in ZNA tokens for storing data on the blockchain. Also, whenever someone uses data of users they will be paid ZNA tokens.

Keep reading
  • Country Russia
  • Organization Zenome Inc.
  • Whitepaper Download
  • Platform Ethereum
  • Coin Type Utility Token
  • Category Healthcare
  • Block Explorer
  • Accepted Currency BTCETH
  • Website

ICO Info

active ICO
(Oct 17, 2017 - Nov 01, 2019)
Total Soft Cap 350,000 USD
Total Max Cap 1,150,000 USD
662,000 USD (58%)
35,000,000 ZNA
Max supply
2.0 USD
Public sale price
N/A
Current price
Token Sale Stages

*Minimum investment: 1 ETH

Stage Start date End date Amount of tokens Price Discount
Stage 0 17 October, 2017 1 November, 2017 353,173 ZNA 0.3 USD 0
Amount of tokens
353,173 ZNA
Price
0.3 USD
Discount
0
Stage 1 1 February, 2018 15 April, 2018 1,046,827 ZNA 0.6 USD 0
Amount of tokens
1,046,827 ZNA
Price
0.6 USD
Discount
0
Stage 2 3 September, 2018 17 September, 2018 1,150,000 ZNA 1.0 USD 0
Amount of tokens
1,150,000 ZNA
Price
1.0 USD
Discount
0
Stage 3 1 March, 2019 1 April, 2019 6,000,000 ZNA 1.5 USD 0
Amount of tokens
6,000,000 ZNA
Price
1.5 USD
Discount
0
Stage 4 1 October, 2019 1 November, 2019 7,200,000 ZNA 2.0 USD 0
Amount of tokens
7,200,000 ZNA
Price
2.0 USD
Discount
0
Distribution
Offered for sale
45%
Offered for sale
45%
Founders
10%
Founders
10%
Reserve as long term incentives
25%
Reserve as long term incentives
25%
Team
6%
Team
6%
Zenome foundation
10%
Zenome foundation
10%
Advisors & bounty
4%
Advisors & bounty
4%
Offered for sale
(45%)
Founders
(10%)
Reserve as long term incentives
(25%)
Team
(6%)
Zenome foundation
(10%)
Advisors & bounty
(4%)
Use of Proceeds
R&D
40%
R&D
40%
Legal
25%
Legal
25%
Operations
11%
Operations
11%
Marketing & sales
24%
Marketing & sales
24%
R&D
(40%)
Legal
(25%)
Operations
(11%)
Marketing & sales
(24%)

People

The team
Alexey Gorbachev
Zenome Inc. / CEO
Nikolay Kulemin
Zenome Inc. / Founder
Vladimir Naumov
Zenome Inc. / Genomic data scientist
Pavel Reutov
Zenome Inc. / Developer
Advisors
Richard Resnick
Zenome Inc. / Senior advisor
Yuri Nikolsky
Zenome Inc. / Advisor in business development
Dmitry Kwon
Zenome Inc. / Advisor
Vadim Pushkarev
Zenome Inc. / Law advisor